Non-Radiometric Thymidine Kinase Assay Kit
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining thymidine kinase (TK) activity in biological samples, particularly in low-level samples like spinal fluid, are inefficient due to the need for radioactive substrates and poor resolution in normal ranges, limiting their use in clinical diagnostics and monitoring.
Innovation Solution
A non-radiometric TK assay that immobilizes the TK product on a solid surface, using a Basic Reaction Mixture with a single-stranded polynucleotide primer or template, a modified deoxy nucleoside substrate, and a kinase enzyme source devoid of TK activity, allowing for sensitive and accurate quantification of TK activity through ELISA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radioactive substrates are used in TK assays, then measurement sensitivity is improved, but safety hazards and regulatory complexity increase
Solution Approach 1:
The patent replaces the radioactive detection system with a non-radioactive ELISA-based detection system. Instead of using radioactive substrates and measuring radioactivity, the invention uses enzyme-linked immunosorbent assay technology to detect TK activity, thereby eliminating radiation safety hazards while maintaining measurement capability
Solution Approach 2:
The patent employs disposable microtiter plates and single-use reagent systems for the ELISA-based TK assay, replacing expensive and regulated radioactive materials with cost-effective, non-radioactive alternatives that do not require special handling or disposal procedures
2Measurement precision
If conventional TK assays are used, then TK activity can be measured, but resolution in normal ranges is poor
Solution Approach 1:
The patent employs a dynamic range optimization strategy where the ELISA assay conditions, antibody concentrations, and substrate incubation times are optimized to provide excellent resolution across the normal physiological range of TK activity, allowing precise differentiation of small changes in TK levels that conventional assays cannot detect
3Measurement precision
If complex assay procedures are used, then measurement accuracy is improved, but ease of operation decreases
Solution Approach 1:
The patent divides the TK assay into discrete, standardized steps using pre-prepared reagent kits with separate containers for each component (substrate, antibodies, buffers). This segmentation allows the complex procedure to be performed systematically with minimal technical expertise, improving ease of operation while maintaining accuracy
Solution Approach 2:
The ELISA-based system is designed to be self-explanatory with built-in controls and standardized protocols that require minimal interpretation or technical judgment, allowing laboratory personnel to perform accurate TK measurements without extensive training or complex procedural decisions
4Measurement precision
If radioactive materials are used, then TK activity can be detected, but cost and regulatory burden increase
Solution Approach 1:
The patent uses disposable, non-radioactive reagents and materials that are inexpensive and do not require regulatory approval for use, eliminating the high costs and bureaucratic burden associated with radioactive material licensing, storage, and disposal while maintaining TK detection capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a simple, inexpensive, and highly sensitive determination of TK activity, overcoming the limitations of existing assays by enabling accurate measurement in low-level samples and improving diagnostic capabilities for cell-proliferation disorders and drug candidate screening.
Implementation Method 1
a kinase enzyme source devoid of TK activity... allowing for sensitive and accurate quantification of TK activity
Implementation Method 2
A non-radiometric TK assay that immobilizes the TK product on a solid surface
Implementation Method 3
allowing for sensitive and accurate quantification of TK activity through ELISA
Data Source
AI summary
An assay kit for determination of thymidine kinase (TK) activity in a biological sample, such as blood, serum, plasma, Cerebral Spinal Fluid (CSF), pleural fluid, ascites, tissues, cells and extracts thereof, is described. The assay kit can used in a method that comprises contacting, in a buffer, a Basic Reaction Mixture comprising: solid surface-attached primer and/or template, a modified deoxy nucleoside, such as BromodeoxyUridine, IododeoxyUridine, FluorodeoxyUridine or VinyldexoyThymidine as a kinase enzyme substrate, a phosphate donor, a nucleotide polymerizing enzyme, and a kinase enzyme source devoid of TK activity, such as a yeast extract, with the biological sample. After incubation the amount of modified deoxy nucleoside that has been incorporated into the solid surface-attached primer and/or template, is determined and the TK activity present in the biological sample is directly proportional to the amount of incorporated modified deoxy nucleoside. The assay kit are useful in the diagnosing, prognosis monitoring of disease progression and treatment effects of cell-proliferation disorders or diseases, such as cancer, and in the screening of compounds, e.g. new drug candidates, affecting enzymatic pathways, which may obstruct the formation of thymidine phosphates or interfere with nucleic acid synthesis.